Westpac Banking Corp’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Westpac Banking Corp’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-47,060	Closed	-$2.26M	–	900
2020 Q1	$2.26M	Sell	47,060 -29,433	-38%	-$1.37M	0.04%	442
2019 Q4	$3.59M	Buy	+76,493	New	+$3.38M	0.05%	444

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Westpac Banking Corp's RARX Position: Q2 2020 in Review

Westpac Banking Corp sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 47,060 shares — an estimated $2.26M sold.

Westpac Banking Corp first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $3.59M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Westpac Banking Corp reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Westpac Banking Corp sold 47,060 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.26M.
Westpac Banking Corp first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Westpac Banking Corp's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.59M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Westpac Banking Corp's 13F filing for Q2 2020, filed 12 Aug 2020.